Novel double-antigen sandwich immunoassay for human hepatitis B core antibody.
about
Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients.Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferaseHigh frequency of CD4+ CXCR5+ TFH cells in patients with immune-active chronic hepatitis BQuantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon.The expression of TLR-9, CD86, and CD95 phenotypes in circulating B cells of patients with chronic viral hepatitis B or C before and after antiviral therapy.Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease.Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis CChlamydia trachomatis Pgp3 Antibody Persists and Correlates with Self-Reported Infection and Behavioural Risks in a Blinded Cohort Study.Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis BAntibody to hepatitis B core antigen levels in the natural history of chronic hepatitis B: a prospective observational study.Development and application of a double-antigen sandwich enzyme-linked immunosorbent assay for detection of antibodies to porcine circovirus 2.Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues.Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment.On-treatment quantitative hepatitis B e antigen predicted response to nucleos(t)ide analogues in chronic hepatitis BNew perspectives of biomarkers for the management of chronic hepatitis B.Serum hepatitis B core antibody titer use in screening for significant fibrosis in treatment-naïve patients with chronic hepatitis B.Low occurrence of HBsAg but high frequency of transient occult HBV infection in vaccinated and HBIG-administered infants born to HBsAg positive mothers.Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase levels.Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.Baseline hepatitis B core antibody predicts treatment response in chronic hepatitis B patients receiving long-term entecavir.Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV-related HCC.Hepatitis B core antibody testing in Indian blood donors: A double-edged sword!Europium (III) chelate microparticle-based lateral flow immunoassay strips for rapid and quantitative detection of antibody to hepatitis B core antigen.Viral Factors Affecting the Clinical Outcomes of Chronic Hepatitis B.PERFORMANCE EVALUATION OF A PROTOTYPE ARCHITECT ANTIBODY ASSAY FOR BABESIA MICROTI.Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs.
P2860
Q33590508-58CF9EC2-7FBA-48DE-8502-F24C0D29ACB6Q33765826-097A29DD-E9FA-40D2-9C2B-555FC669A829Q33959352-E7528D6D-225E-4299-913D-1990C97A2AA4Q34785877-05F11C99-CF91-4C5A-9E7E-55D900C62B1DQ35372981-6663D514-44EA-47E8-B964-76838D63E9D8Q35675909-3B122787-1ED3-4AF5-A123-9F16A2A8D588Q35725505-AF12E26C-392E-4B6C-9E93-3B1BC3C48174Q35956213-9CE4566C-AFC8-4E27-A763-987B2E175038Q36004251-3532AB35-AAA1-4BE6-81D0-B44DD9B2F413Q36151658-BACA5927-E884-4FD4-9598-EED5BF066916Q36191702-F9304736-8C37-4FF2-8F50-DEC02CC0A4E3Q36577343-4909ED68-0C5C-4E43-8794-CFE9917764BDQ37222815-F5F17DA4-7DA1-494E-9DAC-988BD382608BQ37482902-07150A29-572E-4C23-9758-273A4C01A84EQ37606546-76E0E51D-5388-4D24-896A-140F6C56F460Q37706873-A7BB883B-FCDF-47C5-B631-7844718D08FFQ39630343-A17B7E73-CB8E-4ACC-8E13-6FAC0DFBD784Q40122998-94279F35-3F93-4BC3-A117-FE0F3654D1F6Q40291383-8E5A5131-4938-4441-84DA-EBEC9F10ADFFQ40433719-3F472A35-8AB5-4FD3-B24F-8B0D18257CA6Q40806597-878FD195-94FD-4E53-951D-B58637E0B5F6Q42143404-63E79718-C8E6-4EE4-862F-77E39AD055DBQ42621068-2E9BD3FA-5C03-4076-A42A-E221C0CC5ED5Q47575314-E773BD6E-5F52-477C-9E19-EE0D5CA8D9C0Q54216856-3D53F541-A160-4E49-BCF2-0156F225316FQ54234628-D7993D4C-A7CA-4358-82F4-480E0D54BF0D
P2860
Novel double-antigen sandwich immunoassay for human hepatitis B core antibody.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Novel double-antigen sandwich immunoassay for human hepatitis B core antibody.
@ast
Novel double-antigen sandwich immunoassay for human hepatitis B core antibody.
@en
Novel double-antigen sandwich immunoassay for human hepatitis B core antibody.
@nl
type
label
Novel double-antigen sandwich immunoassay for human hepatitis B core antibody.
@ast
Novel double-antigen sandwich immunoassay for human hepatitis B core antibody.
@en
Novel double-antigen sandwich immunoassay for human hepatitis B core antibody.
@nl
prefLabel
Novel double-antigen sandwich immunoassay for human hepatitis B core antibody.
@ast
Novel double-antigen sandwich immunoassay for human hepatitis B core antibody.
@en
Novel double-antigen sandwich immunoassay for human hepatitis B core antibody.
@nl
P2093
P2860
P356
P1476
Novel double-antigen sandwich immunoassay for human hepatitis B core antibody.
@en
P2093
Anthony E T Yeo
Ningshao Xia
Shengxiang Ge
Yixin Chen
P2860
P304
P356
10.1128/CVI.00457-09
P577
2010-01-27T00:00:00Z